img

Global Oral Cholera Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Cholera Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Oral Cholera Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oral Cholera Vaccine market is projected to reach US$ 146.3 million in 2034, increasing from US$ 85 million in 2022, with the CAGR of 7.5% during the period of 2024 to 2034. Demand from Preventive Campaigns and Outbreak Response are the major drivers for the industry.
Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.
South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.
Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Cholera Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax
Segment by Type
Euvichol-Plus
DUKORAL
Shanchol
Others

Segment by Application


Preventive Campaigns
Outbreak Response

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Oral Cholera Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Oral Cholera Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Oral Cholera Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Oral Cholera Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Oral Cholera Vaccine introduction, etc. Oral Cholera Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Oral Cholera Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Oral Cholera Vaccine Market Overview
1.1 Oral Cholera Vaccine Product Overview
1.2 Oral Cholera Vaccine Market Segment by Type
1.2.1 Euvichol-Plus
1.2.2 DUKORAL
1.2.3 Shanchol
1.2.4 Others
1.3 Global Oral Cholera Vaccine Market Size by Type
1.3.1 Global Oral Cholera Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Oral Cholera Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Oral Cholera Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Cholera Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Oral Cholera Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Oral Cholera Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Oral Cholera Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Oral Cholera Vaccine Sales Breakdown by Type (2018-2024)
2 Global Oral Cholera Vaccine Market Competition by Company
2.1 Global Top Players by Oral Cholera Vaccine Sales (2018-2024)
2.2 Global Top Players by Oral Cholera Vaccine Revenue (2018-2024)
2.3 Global Top Players by Oral Cholera Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Oral Cholera Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Cholera Vaccine Market Competitive Situation and Trends
2.5.1 Oral Cholera Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Cholera Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
2.8 Key Manufacturers Oral Cholera Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Cholera Vaccine Status and Outlook by Region
3.1 Global Oral Cholera Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Oral Cholera Vaccine Historic Market Size by Region
3.2.1 Global Oral Cholera Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Oral Cholera Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Oral Cholera Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Oral Cholera Vaccine Forecasted Market Size by Region
3.3.1 Global Oral Cholera Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Oral Cholera Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Oral Cholera Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Oral Cholera Vaccine by Application
4.1 Oral Cholera Vaccine Market Segment by Application
4.1.1 Preventive Campaigns
4.1.2 Outbreak Response
4.2 Global Oral Cholera Vaccine Market Size by Application
4.2.1 Global Oral Cholera Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Oral Cholera Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Oral Cholera Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Cholera Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Oral Cholera Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Oral Cholera Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Oral Cholera Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Oral Cholera Vaccine Sales Breakdown by Application (2018-2024)
5 North America Oral Cholera Vaccine by Country
5.1 North America Oral Cholera Vaccine Historic Market Size by Country
5.1.1 North America Oral Cholera Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Oral Cholera Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Oral Cholera Vaccine Sales in Value by Country (2018-2024)
5.2 North America Oral Cholera Vaccine Forecasted Market Size by Country
5.2.1 North America Oral Cholera Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Oral Cholera Vaccine Sales in Value by Country (2024-2034)
6 Europe Oral Cholera Vaccine by Country
6.1 Europe Oral Cholera Vaccine Historic Market Size by Country
6.1.1 Europe Oral Cholera Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Oral Cholera Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Oral Cholera Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Oral Cholera Vaccine Forecasted Market Size by Country
6.2.1 Europe Oral Cholera Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Oral Cholera Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Oral Cholera Vaccine by Region
7.1 Asia-Pacific Oral Cholera Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Oral Cholera Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Oral Cholera Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Oral Cholera Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Oral Cholera Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Cholera Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Oral Cholera Vaccine Sales in Value by Region (2024-2034)
8 Latin America Oral Cholera Vaccine by Country
8.1 Latin America Oral Cholera Vaccine Historic Market Size by Country
8.1.1 Latin America Oral Cholera Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Oral Cholera Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Oral Cholera Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Oral Cholera Vaccine Forecasted Market Size by Country
8.2.1 Latin America Oral Cholera Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Oral Cholera Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Oral Cholera Vaccine by Country
9.1 Middle East and Africa Oral Cholera Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Oral Cholera Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Oral Cholera Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Oral Cholera Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Oral Cholera Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Cholera Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Oral Cholera Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 PaxVax
10.1.1 PaxVax Company Information
10.1.2 PaxVax Introduction and Business Overview
10.1.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 PaxVax Oral Cholera Vaccine Products Offered
10.1.5 PaxVax Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Oral Cholera Vaccine Products Offered
10.2.5 Sanofi Recent Development
10.3 Valneva
10.3.1 Valneva Company Information
10.3.2 Valneva Introduction and Business Overview
10.3.3 Valneva Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Valneva Oral Cholera Vaccine Products Offered
10.3.5 Valneva Recent Development
10.4 EuBiologics
10.4.1 EuBiologics Company Information
10.4.2 EuBiologics Introduction and Business Overview
10.4.3 EuBiologics Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 EuBiologics Oral Cholera Vaccine Products Offered
10.4.5 EuBiologics Recent Development
10.5 United Biotech
10.5.1 United Biotech Company Information
10.5.2 United Biotech Introduction and Business Overview
10.5.3 United Biotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 United Biotech Oral Cholera Vaccine Products Offered
10.5.5 United Biotech Recent Development
10.6 Vabiotech
10.6.1 Vabiotech Company Information
10.6.2 Vabiotech Introduction and Business Overview
10.6.3 Vabiotech Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Vabiotech Oral Cholera Vaccine Products Offered
10.6.5 Vabiotech Recent Development
10.7 PaxVax
10.7.1 PaxVax Company Information
10.7.2 PaxVax Introduction and Business Overview
10.7.3 PaxVax Oral Cholera Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 PaxVax Oral Cholera Vaccine Products Offered
10.7.5 PaxVax Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Cholera Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Cholera Vaccine Industrial Chain Analysis
11.4 Oral Cholera Vaccine Market Dynamics
11.4.1 Oral Cholera Vaccine Industry Trends
11.4.2 Oral Cholera Vaccine Market Drivers
11.4.3 Oral Cholera Vaccine Market Challenges
11.4.4 Oral Cholera Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Cholera Vaccine Distributors
12.3 Oral Cholera Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Euvichol-Plus
Table 2. Major Company of DUKORAL
Table 3. Major Company of Shanchol
Table 4. Major Company of Others
Table 5. Global Oral Cholera Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Oral Cholera Vaccine Sales by Type (2018-2024) & (K Units)
Table 7. Global Oral Cholera Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Oral Cholera Vaccine Sales by Type (2018-2024) & (US& Million)
Table 9. Global Oral Cholera Vaccine Market Share in Value by Type (2018-2024)
Table 10. Global Oral Cholera Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Oral Cholera Vaccine Sales by Type (2024-2034) & (K Units)
Table 12. Global Oral Cholera Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Oral Cholera Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Oral Cholera Vaccine Sales Market Share in Value by Type (2024-2034)
Table 15. Global Oral Cholera Vaccine Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Oral Cholera Vaccine Sales by Type (2018-2024) & (K Units)
Table 17. North America Oral Cholera Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Oral Cholera Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Europe Oral Cholera Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Oral Cholera Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Oral Cholera Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Oral Cholera Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Latin America Oral Cholera Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Oral Cholera Vaccine Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Oral Cholera Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Oral Cholera Vaccine Sales by Company (2018-2024) & (K Units)
Table 27. Global Oral Cholera Vaccine Sales Share by Company (2018-2024)
Table 28. Global Oral Cholera Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Oral Cholera Vaccine Revenue Share by Company (2018-2024)
Table 30. Global Market Oral Cholera Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Oral Cholera Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Oral Cholera Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Cholera Vaccine as of 2022)
Table 34. Date of Key Manufacturers Enter into Oral Cholera Vaccine Market
Table 35. Key Manufacturers Oral Cholera Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Oral Cholera Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Oral Cholera Vaccine Sales by Region (2018-2024) & (K Units)
Table 39. Global Oral Cholera Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Oral Cholera Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Oral Cholera Vaccine Sales Market Share in Value by Region (2018-2024)
Table 42. Global Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Oral Cholera Vaccine Sales by Region (2024-2034) & (K Units)
Table 44. Global Oral Cholera Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Oral Cholera Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Oral Cholera Vaccine Sales Market Share in Value by Region (2024-2034)
Table 47. Global Oral Cholera Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Oral Cholera Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Oral Cholera Vaccine Sales by Application (2018-2024) & (K Units)
Table 50. Global Oral Cholera Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Oral Cholera Vaccine Sales Market Share in Value by Application (2018-2024)
Table 53. Global Oral Cholera Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Oral Cholera Vaccine Sales by Application (2024-2034) & (K Units)
Table 55. Global Oral Cholera Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Oral Cholera Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Oral Cholera Vaccine Sales Market Share in Value by Application (2024-2034)
Table 58. Global Oral Cholera Vaccine Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Oral Cholera Vaccine Sales by Application (2018-2024) (K Units)
Table 60. North America Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Oral Cholera Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Europe Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Oral Cholera Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Oral Cholera Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Latin America Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Oral Cholera Vaccine Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Oral Cholera Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Oral Cholera Vaccine Sales by Country (2018-2024) & (K Units)
Table 70. North America Oral Cholera Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Oral Cholera Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Oral Cholera Vaccine Sales Market Share in Value by Country (2018-2024)
Table 73. North America Oral Cholera Vaccine Sales by Country (2024-2034) & (K Units)
Table 74. North America Oral Cholera Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Oral Cholera Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Oral Cholera Vaccine Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Oral Cholera Vaccine Sales by Country (2018-2024) & (K Units)
Table 78. Europe Oral Cholera Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Oral Cholera Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Oral Cholera Vaccine Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Oral Cholera Vaccine Sales by Country (2024-2034) & (K Units)
Table 82. Europe Oral Cholera Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Oral Cholera Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Oral Cholera Vaccine Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Oral Cholera Vaccine Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Oral Cholera Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Oral Cholera Vaccine Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Oral Cholera Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Oral Cholera Vaccine Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Oral Cholera Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Oral Cholera Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Oral Cholera Vaccine Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Oral Cholera Vaccine Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Oral Cholera Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Oral Cholera Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Oral Cholera Vaccine Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Oral Cholera Vaccine Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Oral Cholera Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Oral Cholera Vaccine Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Oral Cholera Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Value by Country (2024-2034)
Table 109. PaxVax Company Information
Table 110. PaxVax Introduction and Business Overview
Table 111. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. PaxVax Oral Cholera Vaccine Product
Table 113. PaxVax Recent Development
Table 114. Sanofi Company Information
Table 115. Sanofi Introduction and Business Overview
Table 116. Sanofi Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Sanofi Oral Cholera Vaccine Product
Table 118. Sanofi Recent Development
Table 119. Valneva Company Information
Table 120. Valneva Introduction and Business Overview
Table 121. Valneva Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Valneva Oral Cholera Vaccine Product
Table 123. Valneva Recent Development
Table 124. EuBiologics Company Information
Table 125. EuBiologics Introduction and Business Overview
Table 126. EuBiologics Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. EuBiologics Oral Cholera Vaccine Product
Table 128. EuBiologics Recent Development
Table 129. United Biotech Company Information
Table 130. United Biotech Introduction and Business Overview
Table 131. United Biotech Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. United Biotech Oral Cholera Vaccine Product
Table 133. United Biotech Recent Development
Table 134. Vabiotech Company Information
Table 135. Vabiotech Introduction and Business Overview
Table 136. Vabiotech Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Vabiotech Oral Cholera Vaccine Product
Table 138. Vabiotech Recent Development
Table 139. PaxVax Company Information
Table 140. PaxVax Introduction and Business Overview
Table 141. PaxVax Oral Cholera Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. PaxVax Oral Cholera Vaccine Product
Table 143. PaxVax Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Oral Cholera Vaccine Market Trends
Table 147. Oral Cholera Vaccine Market Drivers
Table 148. Oral Cholera Vaccine Market Challenges
Table 149. Oral Cholera Vaccine Market Restraints
Table 150. Oral Cholera Vaccine Distributors List
Table 151. Oral Cholera Vaccine Downstream Customers
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Cholera Vaccine Product Picture
Figure 2. Global Oral Cholera Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Oral Cholera Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Oral Cholera Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Euvichol-Plus
Figure 6. Global Euvichol-Plus Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of DUKORAL
Figure 8. Global DUKORAL Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Shanchol
Figure 10. Global Shanchol Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Oral Cholera Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Oral Cholera Vaccine Sales Market Share by Type in 2022 & 2034
Figure 15. North America Oral Cholera Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. North America Oral Cholera Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Europe Oral Cholera Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Europe Oral Cholera Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Latin America Oral Cholera Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Oral Cholera Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Cholera Vaccine Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Cholera Vaccine Revenue in 2022
Figure 27. Oral Cholera Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Preventive Campaigns
Figure 29. Global Preventive Campaigns Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Outbreak Response
Figure 31. Global Outbreak Response Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Global Oral Cholera Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Oral Cholera Vaccine Sales Market Share by Application in 2022 & 2034
Figure 34. North America Oral Cholera Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Oral Cholera Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Oral Cholera Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Oral Cholera Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Oral Cholera Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Oral Cholera Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Oral Cholera Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Oral Cholera Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Oral Cholera Vaccine Manufacturing Cost Structure
Figure 45. Oral Cholera Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries